￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of whether relapse will occur after discontinuation of baricitinib/alamine

2026-02-01 22:25:32

Check Details
The combination of tucatinib/tucatinib and T-DM1

2026-02-01 22:25:32

Check Details
Is Alpelisib produced in India a generic drug?

2026-02-01 22:25:32

Check Details
What diseases does fostatinib/fotantinib mainly treat?

2026-02-01 22:25:32

Check Details
Comparative analysis of the efficacy of seputinib/serpatinib (Ruitu) and osimertinib

2026-02-01 22:25:32

Check Details
Is Anamorelin a proton pump inhibitor and why?

2026-02-01 22:25:32

Check Details
Is baricitinib/alemin a biologic drug?

2026-02-01 22:25:32

Check Details
Is the brand introduction of tucatinib/tucatinib generic drug reliable?

2026-02-01 22:25:32

Check Details
Storage conditions of aprocitentan and methods to avoid reduction in efficacy

2026-02-01 22:25:32

Check Details
What are the specific indications for Alpelisib?

2026-02-01 22:25:32

Check Details
None

2026-02-01 22:25:32

Check Details
Domestic listing status and sales channel description of Tirpotide/Tirzepatide

2026-02-01 22:25:32

Check Details
Category
相关知识